“…We are grateful to Thiebaud et al . [1] for their comments about external validation and comparison of four risk scores in patients with upper gastrointestinal bleeding [2]. Even if the AIMS65 does not seem to have any advantage, it is important to assess all prognostic models in a European healthcare system.…”